Cours GB Sciences, Inc. Other OTC
Actions
GBLX
US3615441090
Recherche biotechnologique et médicale
CA 2022 | - | CA 2023 | - | Capitalisation | 6,83 M 6,16 M |
---|---|---|---|---|---|
Résultat net 2022 | - 0 | Résultat net 2023 | -4 M -3,61 M | VE / CA 2022 | - |
Dette nette 2022 | 1,15 M 1,04 M | Dette nette 2023 | 1,29 M 1,16 M | VE / CA 2023 | - |
PER 2022 |
-16,8
x | PER 2023 |
-1,56
x | Employés | - |
Rendement 2022 * |
-
| Rendement 2023 |
-
| Flottant | 87,78% |
Dirigeants | Titre | Age | Depuis |
---|---|---|---|
John Poss
CEO | Chief Executive Officer | 76 | 27/07/15 |
President | 54 | 10/06/14 | |
Monica Poss
PRN | Corporate Officer/Principal | - | 01/09/18 |
Administrateurs | Titre | Age | Depuis |
---|---|---|---|
President | 54 | 10/06/14 | |
John Poss
CEO | Chief Executive Officer | 76 | 27/07/15 |
Varia. 1 janv. | Capi. | |
---|---|---|
+43,36% | 54,63 Md | |
-5,31% | 39,92 Md | |
+37,52% | 38,82 Md | |
+14,75% | 26,86 Md | |
-12,56% | 26,22 Md | |
-22,45% | 18,78 Md | |
+25,12% | 12,21 Md | |
+0,04% | 12,16 Md | |
+26,04% | 11,94 Md |